Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

8.40
BATS BZX Real-Time Price
As of 1:38pm ET
 +0.50 / +6.33%
Today’s Change
7.00
Today|||52-Week Range
17.20
-30.86%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close7.90
Today’s open7.95
Day’s range7.95 - 8.40
Volume6,996
Average volume (3 months)688,072
Market cap$425.7M
Data as of 1:38pm ET, 12/13/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-715.02%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+271.30%
P/E ratioNM
Price/Sales4.86
Price/Book3.40

Competitors

 Today’s
change
Today’s
% change
VNDAVanda Pharmaceutical...+0.45+3.31%
FLXNFlexion Therapeutics...+0.17+0.68%
ACRSAclaris Therapeutics...-0.05-0.20%
AKBAAkebia Therapeutics ...+0.11+0.72%
Data as of 1:40pm ET, 12/13/2017

Financials

Next reporting dateFebruary 15, 2018
EPS forecast (this quarter)-$0.69
Annual revenue (last year)$106.4M
Annual profit (last year)$16.5M
Net profit margin15.46%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer &
Senior Vice President
Ching Jaw
Corporate headquarters
South San Francisco, California

Forecasts